Whitehawk Therapeutics, Inc. · NASDAQ:WHWK
Orbimed Advisors LLC reported a 7.30% stake in Whitehawk Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Orbimed Advisors LLC reported a 7.30% stake in Whitehawk Therapeutics, Inc., 3,934,296 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 7.30%
- Shares
- 3,934,296
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OrbiMed Advisors LLC | 7.30% | 3,934,296 |
| OrbiMed Genesis GP LLC | 7.30% | 3,934,296 |
Source
Related
- Whitehawk Therapeutics, Inc.
- Orbimed Advisors LLC
- Whitehawk Therapeutics, Inc. shareholders
- Schedule 13G · Orbimed Advisors LLC · May 15, 2025
- Schedule 13G/A · Fan Yu · Aug 14, 2026
- Form 4 · Dalal Anupam · Jul 30, 2026
- Form 4 · Dugan Margaret · May 18, 2026
- Form 4 · Ball Bryan · May 18, 2026
- Form 4 · Giacobello Scott M. · May 18, 2026